ARCADIS NV (ARCAD.AS)

NL0006237562 - Common Stock

65.15  -0.9 (-1.36%)

Fundamental Rating

5

Taking everything into account, ARCAD scores 5 out of 10 in our fundamental rating. ARCAD was compared to 31 industry peers in the Professional Services industry. Both the profitability and the financial health of ARCAD get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, ARCAD is valued expensive at the moment.



6

1. Profitability

1.1 Basic Checks

In the past year ARCAD was profitable.
In the past year ARCAD had a positive cash flow from operations.
Each year in the past 5 years ARCAD has been profitable.
ARCAD had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

ARCAD has a Return On Assets (4.95%) which is in line with its industry peers.
ARCAD's Return On Equity of 16.91% is fine compared to the rest of the industry. ARCAD outperforms 66.67% of its industry peers.
The Return On Invested Capital of ARCAD (9.73%) is better than 63.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ARCAD is below the industry average of 11.04%.
The 3 year average ROIC (9.02%) for ARCAD is below the current ROIC(9.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.95%
ROE 16.91%
ROIC 9.73%
ROA(3y)4.6%
ROA(5y)2.98%
ROE(3y)14.89%
ROE(5y)9.62%
ROIC(3y)9.02%
ROIC(5y)8.59%

1.3 Margins

Looking at the Profit Margin, with a value of 5.02%, ARCAD is in line with its industry, outperforming 56.67% of the companies in the same industry.
In the last couple of years the Profit Margin of ARCAD has grown nicely.
With a decent Operating Margin value of 8.96%, ARCAD is doing good in the industry, outperforming 63.33% of the companies in the same industry.
ARCAD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.96%
PM (TTM) 5.02%
GM N/A
OM growth 3Y0.26%
OM growth 5Y7.36%
PM growth 3Y77.81%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ARCAD is still creating some value.
Compared to 1 year ago, ARCAD has more shares outstanding
The number of shares outstanding for ARCAD has been increased compared to 5 years ago.
Compared to 1 year ago, ARCAD has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.02 indicates that ARCAD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.02, ARCAD is in line with its industry, outperforming 53.33% of the companies in the same industry.
ARCAD has a debt to FCF ratio of 4.06. This is a neutral value as ARCAD would need 4.06 years to pay back of all of its debts.
ARCAD has a Debt to FCF ratio of 4.06. This is in the better half of the industry: ARCAD outperforms 63.33% of its industry peers.
ARCAD has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
ARCAD has a worse Debt to Equity ratio (1.06) than 63.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 4.06
Altman-Z 3.02
ROIC/WACC1.53
WACC6.34%

2.3 Liquidity

A Current Ratio of 1.31 indicates that ARCAD should not have too much problems paying its short term obligations.
ARCAD has a Current ratio (1.31) which is comparable to the rest of the industry.
ARCAD has a Quick Ratio of 1.31. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
ARCAD's Quick ratio of 1.31 is in line compared to the rest of the industry. ARCAD outperforms 56.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31

6

3. Growth

3.1 Past

ARCAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.56%, which is quite impressive.
The Earnings Per Share has been growing by 104.18% on average over the past years. This is a very strong growth
The Revenue has grown by 9.91% in the past year. This is quite good.
ARCAD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.03% yearly.
EPS 1Y (TTM)67.56%
EPS 3Y104.18%
EPS 5YN/A
EPS Q2Q%61.7%
Revenue 1Y (TTM)9.91%
Revenue growth 3Y14.66%
Revenue growth 5Y9.03%
Sales Q2Q%4.87%

3.2 Future

ARCAD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.30% yearly.
ARCAD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.92% yearly.
EPS Next Y18.84%
EPS Next 2Y18.99%
EPS Next 3Y17.98%
EPS Next 5Y17.3%
Revenue Next Year19.67%
Revenue Next 2Y13.02%
Revenue Next 3Y11.4%
Revenue Next 5Y6.92%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 30.59, which means the current valuation is very expensive for ARCAD.
Based on the Price/Earnings ratio, ARCAD is valued a bit more expensive than 60.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 31.71, ARCAD is valued at the same level.
With a Price/Forward Earnings ratio of 17.36, ARCAD is valued on the expensive side.
ARCAD's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of ARCAD to the average of the S&P500 Index (22.81), we can say ARCAD is valued slightly cheaper.
Industry RankSector Rank
PE 30.59
Fwd PE 17.36

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARCAD indicates a slightly more expensive valuation: ARCAD is more expensive than 63.33% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARCAD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 18.58
EV/EBITDA 13.53

4.3 Compensation for Growth

ARCAD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ARCAD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ARCAD's earnings are expected to grow with 17.98% in the coming years.
PEG (NY)1.62
PEG (5Y)N/A
EPS Next 2Y18.99%
EPS Next 3Y17.98%

4

5. Dividend

5.1 Amount

ARCAD has a Yearly Dividend Yield of 1.29%.
ARCAD's Dividend Yield is comparable with the industry average which is at 2.95.
Compared to an average S&P500 Dividend Yield of 2.18, ARCAD's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

On average, the dividend of ARCAD grows each year by 35.08%, which is quite nice.
Dividend Growth(5Y)35.08%
Div Incr Years5
Div Non Decr Years5

5.3 Sustainability

39.52% of the earnings are spent on dividend by ARCAD. This is a low number and sustainable payout ratio.
The dividend of ARCAD is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP39.52%
EPS Next 2Y18.99%
EPS Next 3Y17.98%

ARCADIS NV

AMS:ARCAD (10/21/2024, 5:29:51 PM)

65.15

-0.9 (-1.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.88B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 30.59
Fwd PE 17.36
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.62
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.95%
ROE 16.91%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.96%
PM (TTM) 5.02%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)67.56%
EPS 3Y104.18%
EPS 5Y
EPS Q2Q%
EPS Next Y18.84%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.91%
Revenue growth 3Y14.66%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y